Do Weight Loss Injections Affect Muscle Mass?

Why any calorie deficit touches muscle, not just fat

The body does not burn fat exclusively when it is in a calorie deficit. Even under ideal conditions, a proportion of the weight lost during any diet comes from lean tissue, which includes muscle. How large that proportion is depends on how fast weight is lost, how much protein is eaten, whether resistance exercise is part of the routine, and how much fat the body has to draw on in the first place.

GLP-1 medicines like semaglutide (Wegovy) and the dual GIP/GLP-1 agonist tirzepatide (Mounjaro) work partly by reducing appetite significantly, which means calorie intake drops, sometimes steeply, especially in the first weeks of treatment. That rapid reduction is effective for weight loss, but it raises the muscle-preservation question more acutely than a gentle, self-managed diet might. The NHS's guidance on tirzepatide for patients notes that these medicines should be used alongside a reduced-calorie diet and increased physical activity, and that pairing is not decorative advice. It is specifically there to protect metabolic health, which includes lean mass.

So the question is not really whether muscle loss is possible (it is, as with any weight-loss approach), but whether it is worse with injections than with other methods, and what you can do about it. That is the decision this page is designed to help you think through.

What clinical trials tell us about muscle and GLP-1 treatment

The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that participants on tirzepatide 15mg lost around 20–21% of body weight on average over 72 weeks. Detailed body-composition analyses from the wider tirzepatide programme found that a meaningful share of that weight loss came from fat mass, with lean mass losses proportionally smaller, though not zero. Similar patterns emerged in semaglutide trials: the STEP programme reported average weight reductions of around 15% over 68 weeks, with the majority attributable to fat tissue.

Crucially, participants who exercised more and ate more protein during treatment showed better preservation of lean mass. This is consistent with the established physiology: muscle responds to load and to amino acid availability, both of which you can influence regardless of what medicine you are taking. Sitting with a very small appetite and not lifting anything heavier than a shopping bag is a different situation from training two or three times a week and hitting a protein target.

One practical consideration worth flagging: when appetite is suppressed, getting enough protein feels harder than usual. Some people find that planning protein-containing food first in a meal (before appetite disappears mid-plate) makes a real difference. It is the kind of habit that sounds small but compounds over months. You can read more about how these injections work across different aspects of the body in our overview of weight loss injections and muscle mass.

The practical decision: how to protect lean mass on treatment

If you are considering GLP-1 treatment, the muscle question is worth raising explicitly with a prescriber rather than leaving it as background anxiety. A clinician who knows your starting point (current activity level, protein habits, any existing muscle or bone concerns) can shape your plan accordingly. Our clinical team reviews each consultation individually; it is not a checkbox exercise.

The levers you have are well-supported by evidence. Resistance training (weights, resistance bands, bodyweight work) signals the body to hold on to muscle even when calories are low. Protein distribution across the day matters more than a single high-protein meal. Gradual dose titration, which is how both Mounjaro and Wegovy are prescribed anyway, means appetite suppression builds incrementally rather than arriving all at once, giving you time to adapt your eating habits rather than facing a sudden calorie cliff.

For context on the broader cost and access picture, our guide to how much weight loss injections cost covers what private treatment typically includes. And if you want to understand how different injection-based treatments compare, including newer options such as the Novartis weight loss injection, the weight loss injections overview sets out the licensed options in the UK.

It is also worth knowing that effects on the body extend beyond muscle. For a closer look at what the research says specifically about weight loss injections and muscle loss, we have put together a dedicated guide that our prescribers recommend to patients with this concern. We have also covered what the evidence says about how weight loss injections affect the liver, which is a question our prescribers hear regularly.

One point many people overlook: the medicines are stored in the fridge, and people who keep them in the fridge door alongside everyday items tend to find the weekly routine easier to maintain. Consistent use, not occasional use, is what the trial data reflects. These are prescription-only medicines, and the prescriber who approves your treatment can flag anything that needs adjusting, including signs that lean mass is being lost faster than expected.

Report any suspected side effects via the MHRA's Yellow Card scheme, including unexpected changes in strength or physical capacity.